
BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our passionate interest in fighting cancer.
Internship program dates: June 8 - August 21, 2026
Education Required:
General Description/Scope of Responsibilities (Internship):
The Accounting Intern – Latin America will support BeOne Medicines’ regional accounting operations, partnering with internal stakeholders and in-country service providers to ensure accurate, timely and compliant accounting across multiple Latin American countries, in alignment with BeOne’s global policies and ways of working.
Essential Functions of the Internship:
• Support month-end close and reporting activities.
• Prepare and maintain account reconciliations.
• Assist with statutory and management reporting for LATAM entities.
• Monitor and support key internal accounting metrics, such as close cycle time, reconciliation aging, and audit findings.
• Support internal controls and audit requests.
• Support continuous improvement and process documentation initiatives
• Participate in continuous improvement initiatives.
• Support Associate Manager on Accounting projects
Supervisory Responsibilities:
Computer Skills:
Other Qualifications (one or more):
Pay Rates:
Bachelors: $15/hour BRL
Global Competencies
When we exhibit our values of Patients First, Driving Excellence, Bold Ingenuity, and Collaborative Spirit, through our twelve global competencies below, we help get more affordable medicines to more patients around the world.
We are proud to be an equal opportunity employer. BeOne does not discriminate on the basis of race, religion, color, sex, gender identity, sexual orientation, age, disability, national origin, veteran status or any other basis covered by appropriate law. All employment is decided on the basis of qualifications, merit, and business need.

Effective March 17, 2025, The U.S. subsidiary of BeiGene, Ltd. has changed its name to BeOne Medicines USA, Inc. This change comes ahead of our anticipated global rebranding to BeOne Medicines Ltd. and redomiciliation to Switzerland, pending shareholder approval. The new name reflects our commitment to develop innovative medicines and partner with the global community to help as many patients with cancer as possible.
To learn more about BeOne Medicines, please follow our new LinkedIn profile @BeOne Medicines.